Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited financial results for Q2 FY26 and H1 FY26 on November 12, 2025. On a standalone basis, revenue from operations dipped to Rs. 48.74 crore in Q2 (vs Rs. 50.60 crore a year ago, down ~3.7%) and to Rs. 101.90 crore for H1 (vs Rs. 104.92 crore). Standalone profit after tax rose modestly to Rs. 3.89 crore in Q2 (vs Rs. 3.73 crore) and to Rs. 11.17 crore in H1 (vs Rs. 9.48 crore). On a consolidated basis, the picture was weaker: Q2 revenue fell to Rs. 49.13 crore (vs Rs. 56.10 crore, down ~12.4%) and H1 PAT dropped sharply to Rs. 8.53 crore (vs Rs. 12.13 crore, down ~30%). Operating cash flow turned negative for H1 (standalone -Rs. 4.92 crore, consolidated -Rs. 5.21 crore). The statutory auditor issued an unmodified review report but flagged the ongoing Bombay High Court winding-up matter (interim stay since 2015) as an emphasis of matter.
Mixed-to-weak set of numbers: revenue is declining on both standalone and consolidated bases, consolidated profits fell sharply, and operating cash flow is negative in H1, which may concern investors. However, standalone profits are still growing and the auditor's clean report softens the negative read; the old winding-up legal overhang remains a watch item.